(Q44189408)

30 November 2017

title

Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35. (English)

1 reference

30 November 2017

1 reference

1 reference

4

Hilkka Soininen

1 reference

30 November 2017

Petri Kerokoski

1

1 reference

30 November 2017

Tiina Suuronen

series ordinal

2

1 reference

30 November 2017

Antero Salminen

series ordinal

3

1 reference

30 November 2017

Tuula Pirttilä

series ordinal

5

1 reference

30 November 2017

publication date

1 October 2002

1 reference

30 November 2017

published in

Molecular Brain Research

1 reference

30 November 2017

volume

106

1 reference

30 November 2017

issue

1-2

1 reference

30 November 2017

page(s)

50-56

1 reference

Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Cyclin-dependent protein kinase 5 activity increases in rat brain following ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Expression of cyclin-dependent kinase 5 and its activator p35 in rat brain after middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Impaired proteasome function in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Neurotoxicity induces cleavage of p35 to p25 by calpain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

A brain-specific activator of cyclin-dependent kinase 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Proteasomal function is impaired in substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Processing of cdk5 Activator p35 to Its Truncated Form (p25) by Calpain in Acutely Injured Neuronal Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2802%2900409-6

7 January 2021

10.1016/S0169-328X(02)00409-6

Identifiers

DOI

1 reference

30 November 2017

1 reference